Time To Start

In a recent interview with Forbes' Matthew Herper, Dendreon's retiring chief scientist, David Urdal, weighs in on the lack of new drugs in the past few years. When Herper asks him why the drug business is "in such a profound innovation drought," Urdal says the dynamics of drug innovation have changed from when he began to work in the biotech industry.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.